Cargando…

Novel immune modulatory vaccines targeting TGFβ

Detalles Bibliográficos
Autor principal: Andersen, Mads Hald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040921/
https://www.ncbi.nlm.nih.gov/pubmed/36973484
http://dx.doi.org/10.1038/s41423-023-01000-5
_version_ 1784912593301798912
author Andersen, Mads Hald
author_facet Andersen, Mads Hald
author_sort Andersen, Mads Hald
collection PubMed
description
format Online
Article
Text
id pubmed-10040921
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100409212023-03-27 Novel immune modulatory vaccines targeting TGFβ Andersen, Mads Hald Cell Mol Immunol Comment Nature Publishing Group UK 2023-03-27 2023-05 /pmc/articles/PMC10040921/ /pubmed/36973484 http://dx.doi.org/10.1038/s41423-023-01000-5 Text en © The Author(s), under exclusive licence to CSI and USTC 2023
spellingShingle Comment
Andersen, Mads Hald
Novel immune modulatory vaccines targeting TGFβ
title Novel immune modulatory vaccines targeting TGFβ
title_full Novel immune modulatory vaccines targeting TGFβ
title_fullStr Novel immune modulatory vaccines targeting TGFβ
title_full_unstemmed Novel immune modulatory vaccines targeting TGFβ
title_short Novel immune modulatory vaccines targeting TGFβ
title_sort novel immune modulatory vaccines targeting tgfβ
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040921/
https://www.ncbi.nlm.nih.gov/pubmed/36973484
http://dx.doi.org/10.1038/s41423-023-01000-5
work_keys_str_mv AT andersenmadshald novelimmunemodulatoryvaccinestargetingtgfb